TARGETING CHRONIC PAIN
Approximately 100 million American adults suffer from chronic pain with an estimated societal cost of $600 billion annually.
Chronic pain continues to be an enormous unmet medical need with a far-reaching impact on society.
ProNeurogen’s PNA5 Drug Candidate
•Novel approach – new drug class
•Efficacious for chronic and inflammatory pain
•Extremely safe e.g., non-addictive with preclinical studies showing no side-effects